Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Syros Pharmaceuticals Inc SYRS

Healthcare Biotechnology

Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with hematologic malignancies. The Company is advancing Tamibarotene, a selective retinoic acid receptor alpha (RARa), agonist for which the Company is conducting SELECT-MDS-1, a Phase III clinical trial evaluating tamibarotene in... see more

Add To Watchlist

Bullboard (NDAQ:SYRS)

View:

Post by whytestockson Sep 05, 2024 11:47am

Bronstein, Gewirtz and Grossman, LLC Is Investigating Syros

NEWS: $SYRS Bronstein, Gewirtz and Grossman, LLC Is Investigating Syros Pharmaceuticals, Inc. (SYRS) And Encourages Investors to ConnectNEW YORK CITY, NY / ACCESSWIRE / September 5, 2024 / Bronstein ...more

Post by whytestockson Aug 29, 2024 1:45pm

Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharma

Just In: $SYRS Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharmaceuticals, Inc. (SYRS) Stockholders to Inquire about Securities InvestigationNEW YORK CITY, NY / ACCESSWIRE / August 29, 2024 ...more

164